Literature DB >> 24093525

Subtypes of attention deficit-hyperactivity disorder (ADHD) and cannabis use.

Mallory Loflin1, Mitch Earleywine, Joseph De Leo, Andrea Hobkirk.   

Abstract

The current study examined the association between subtypes of attention-deficit/hyperactivity disorder (ADHD) and cannabis use within a sample of 2811 current users. Data were collected in 2012 from a national U.S. survey of cannabis users. A series of logistic regression equations and chi-squares were assessed for proportional differences between users. When asked about the ADHD symptoms they have experienced when not using cannabis, a higher proportion of daily users met symptom criteria for an ADHD diagnoses of the subtypes that include hyperactive-impulsive symptoms than the inattentive subtype. For nondaily users, the proportions of users meeting symptom criteria did not differ by subtype. These results have implications for identifying which individuals with ADHD might be more likely to self-medicate using cannabis. Furthermore, these findings indirectly support research linking relevant cannabinoid receptors to regulatory control.

Entities:  

Mesh:

Year:  2013        PMID: 24093525     DOI: 10.3109/10826084.2013.841251

Source DB:  PubMed          Journal:  Subst Use Misuse        ISSN: 1082-6084            Impact factor:   2.164


  7 in total

1.  Activation of cannabinoid system in anterior cingulate cortex and orbitofrontal cortex modulates cost-benefit decision making.

Authors:  Abbas Khani; Mojtaba Kermani; Soghra Hesam; Abbas Haghparast; Enrike G Argandoña; Gregor Rainer
Journal:  Psychopharmacology (Berl)       Date:  2014-12-23       Impact factor: 4.530

2.  Daily, but not occasional, cannabis use is selectively associated with more impulsive delay discounting and hyperactive ADHD symptoms in binge-drinking young adults.

Authors:  Tashia Petker; Mark Ferro; Michael Van Ameringen; James Murphy; James MacKillop
Journal:  Psychopharmacology (Berl)       Date:  2021-02-27       Impact factor: 4.530

3.  ADHD Is Highly Prevalent in Patients Seeking Treatment for Cannabis Use Disorders.

Authors:  Daniel P Notzon; Martina Pavlicova; Andrew Glass; John J Mariani; Amy L Mahony; Daniel J Brooks; Frances R Levin
Journal:  J Atten Disord       Date:  2016-03-31       Impact factor: 3.256

4.  Attention-deficit/hyperactivity disorder and lifetime cannabis use: genetic overlap and causality.

Authors:  María Soler Artigas; Cristina Sánchez-Mora; Paula Rovira; Vanesa Richarte; Iris Garcia-Martínez; Mireia Pagerols; Ditte Demontis; Sven Stringer; Jacqueline M Vink; Anders D Børglum; Benjamin M Neale; Barbara Franke; Stephen V Faraone; Miguel Casas; Josep Antoni Ramos-Quiroga; Marta Ribasés
Journal:  Mol Psychiatry       Date:  2019-01-04       Impact factor: 13.437

5.  Attention deficit hyperactivity disorder symptoms and cannabis use after one year among students of the i-Share cohort.

Authors:  François Arnaud Matthieu Jean; Julie Arsandaux; Ilaria Montagni; Ophélie Collet; Mélina Fatséas; Marc Auriacombe; Josep Antoni Ramos-Quiroga; Sylvana M Côté; Christophe Tzourio; Cédric Galéra
Journal:  Eur Psychiatry       Date:  2022-03-29       Impact factor: 7.156

6.  Predicting Self-Medication with Cannabis in Young Adults with Hazardous Cannabis Use.

Authors:  Dorothy Wallis; J Douglas Coatsworth; Jeremy Mennis; Nathaniel R Riggs; Nikola Zaharakis; Michael A Russell; Aaron R Brown; Stephanie Rayburn; Aubrie Radford; Christopher Hale; Michael J Mason
Journal:  Int J Environ Res Public Health       Date:  2022-02-07       Impact factor: 3.390

7.  Differences in alcohol and cannabis use amongst substance use disorder patients with and without comorbid attention-deficit/hyperactivity disorder.

Authors:  Corné Coetzee; Ilse Truter; Anneke Meyer
Journal:  S Afr J Psychiatr       Date:  2022-04-14       Impact factor: 1.242

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.